GlassScriptPhysician profile
Gilbert Zoghbi
NPI 1306856851
$7,755.76
in general payments reported to CMS, 2019-2025
27 companies · $1,470 in 2025
The $1,470 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,704 · 2020: $257 · 2021: $309 · 2022: $815 · 2023: $1,030 · 2024: $1,171 · 2025: $1,470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,670.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,212.88 | 2019-2020 | |
| Edwards Lifesciences Corporation | $1,110.63 | 2020-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $858.44 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Ffrangio |
| Abiomed | $518.40 | 2021-2025 | Impella |
| Boston Scientific Corporation | $496.93 | 2019-2024 | Avvigo Guidance System, Watchman Flx, Wolverine Coronary Cutting Balloon |
| Abbott Laboratories | $413.93 | 2022-2025 | Cardiomems, Navitor, Jeti Peripheral Catheter |
| Livanova USA, INC. | $357.38 | 2019-2023 | Lifesparc |
| Zoll Circulation INC | $276.32 | 2024-2025 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Heartflow, INC. | $259.30 | 2025 | |
| Novartis Pharmaceuticals Corporation | $195.33 | 2019-2025 | |
| Biotronik INC. | $155.77 | 2019-2025 | Solia, Acticor 7 Vr-T Dx, Amvia Edge |
| E.R. Squibb & Sons, L.L.C. | $130.21 | 2019-2023 | Camzyos, Eliquis |
| Philips North America LLC | $127.81 | 2022-2024 | (Cm9) Amb Mon & Diag Und |
| Penumbra, INC. | $125.55 | 2023 | Indigo System |
| Actelion Pharmaceuticals US, INC. | $119.88 | 2019-2023 | Uptravi, Opsumit |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $77.23 | 2025 | Repatha |
| Pfizer INC. | $62.55 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $55.58 | 2025 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $54.63 | 2024 | Farxiga |
| Cook Medical LLC | $29.53 | 2025 | Zilver Ptx, Rosen |
| Stryker Corporation | $28.06 | 2025 | Artix Mt |
| Janssen Pharmaceuticals, INC | $27.31 | 2022 | |
| Shockwave Medical, INC | $23.08 | 2020 | |
| Merck Sharp & Dohme LLC | $16.27 | 2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.64 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.12 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Zoghbi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.